Management of patients with hidradenitis suppurativa during COVID-19 vaccination: an experience from southern Italy. Comment on: ‘Evaluating the safety and efficacy of COVID-19 vaccination in patients with hidradenitis suppurativa’-Reference-Cited by-同舟云学术

Management of patients with hidradenitis suppurativa during COVID-19 vaccination: an experience from southern Italy. Comment on: ‘Evaluating the safety and efficacy of COVID-19 vaccination in patients with hidradenitis suppurativa’

Published:2022-11-01 Issue:11 Volume:47 Page:2026-2028
ISSN:1365-2230
Container-title:Clinical and Experimental Dermatology
language:en
Short-container-title:

Author:

Martora Fabrizio¹^ORCID,Marasca Claudio¹^ORCID,Battista Teresa¹,Fabbrocini Gabriella¹,Ruggiero Angelo¹^ORCID

Affiliation:

1. Dermatology Unit, Department of Clinical Medicine and Surgery University of Naples Federico II Naples Italy

Publisher

Oxford University Press (OUP)

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ced.15306

Reference9 articles.

1. Impact of the COVID-19 pandemic on hospital admissions of patients with rare diseases: an experience of a Southern Italy referral center;Martora;Int J Dermatol,2022

2. May COVID-19 outbreaks lead to a worsening of skin chronic inflammatory conditions?;Marasca;Med Hypotheses,2020

3. Evaluating the safety and efficacy of COVID-19 vaccination in patients with hidradenitis suppurativa;Pakhchanian;Clin Exp Dermatol,2022

4. Biologics for patients affected by hidradenitis suppurativa in the COVID-19 era: data from a referral center of Southern Italy;Marasca;J Dermatolog Treat,2022

5. Hidradenitis suppurativa flares following COVID-19 vaccination: a case series;Martora;JAAD Case Rep,2022

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hidradenitis Suppurativa in Elderly Patients: Clinical and Therapeutical Outcomes—A Review of the Literature;Medicina;2024-09-06

2. Could Vaccination against COVID-19 Trigger Immune-Mediated Inflammatory Diseases?;Journal of Clinical Medicine;2024-08-07

3. Exploring teledermatology in managing common inflammatory skin conditions: a systematic review;Journal of Health Sciences and Medicine;2024-05-27

4. Secukinumab for Severe Hidradenitis Suppurativa in a Patient on Haemodialysis: Efficacy and Safety on 300 mg Every 2 Weeks Administration – A Case Report;Clinical, Cosmetic and Investigational Dermatology;2024-05

5. Viral reactivation following COVID-19 vaccination: a review of the current literature;Clinical and Experimental Dermatology;2024-02-20